baber/WOPTO huggingface dataset:
Patent CA-2683964-A1 (CA)
Inventor: OTSUKA HIROSHI
IPC: A47L13/256
Filed: 2008-04-25
Abstract: Disclosed is a cleaning sheet (1) including at least one long-fiber assembly (10), in which long fibers (11) are assembled by orienting them substantially in one direction. The long fibers (11) are jointed by one first joint line (12) continuously extending in a direction perpendicular to the orienting direction, and are also jointed by a plurality of second joint lines (13) extending in the orienting direction. These joints establish the assembly state of the long fibers (11) in the long-fiber assembly (10). It is preferred that the first joint line (12) and the second joint lines (13) are connected.
Patent CA-2684043-A1 (CA)
Title: Modular fence device
Inventor: CHUNG MIN-JUN
IPC: E04H17/14
Filed: 2009-10-27
Abstract: A modular fence device includes a plurality of spaced-apart rods connected between upper and lower beams, a plurality of upper spacers each disposed between top ends of two adjacent ones of the rods, and a plurality of lower spacers each disposed between bottom ends of the two adjacent ones of the rods. Each of the upper and lower beams includes a rail member defining a groove and having two opposite longitudinal rail walls, two spacer retainers extending longitudinally on the respective longitudinal rail walls, and two rail tracks extending above the spacer retainers.  The top and bottom ends of each rod respectively extend into the grooves in the rail members of the upper and lower beams, and have a pair of slide protrusions projecting transversely and oppositely therefrom and engaging respectively and slidably the rail tracks of the rail members of the upper and lower beams.
Patent CA-2684190-A1 (CA)
Title: Post-render graphics overlays
Inventor: ELMIEH BABACK
IPC: G06T15/50
Filed: 2008-05-07
Abstract: In general, the present disclosure describes various techniques for overlaying or combining a set of rendered graphics surfaces onto a single graphics frame. One example device includes a first processor that selects a surface level for each of a plurality of rendered graphics surfaces prior to the device outputting any of the rendered graphics surfaces to a display. The device further includes a second processor that retrieves the rendered graphics surfaces, overlays the rendered graphics surfaces onto a graphics frame in accordance with each of the selected surface levels, and outputs the graphics frame to the display.
Patent CA-2684472-A1 (CA)
Title: Methods, devices, and systems for automated movements involving medical robots
Inventor: NEWHOOK PERRY
IPC: B25J9/02
Filed: 2008-04-16
Abstract: Methods, devices (such as computer readable media), and systems (such as computer systems) for defining and executing automated movements using robotic arms (such as robotic arms configured for use in performing surgical procedures), so that a remotely-located surgeon is relieved from causing the robotic arm to perform the automated movement through movement of an input device such as a hand controller.
Patent CA-2685009-A1 (CA)
Inventor: ANDERSEN PAUL JOSEPH
IPC: B01J29/85
Filed: 2008-04-24
Abstract: A method of converting nitrogen oxides in a gas to nitrogen by contacting the nitrogen oxides with a nitrogenous reducing agent in the' presence of a zeolite catalyst containing at least one transition metal, wherein the zeolite is a small pore zeolite containing a maximum ring size of eight tetrahedral atoms, wherein the at least one transition metal is selected from the group consisting of Cr, Mn, Fe, Co, Ce, Ni, Cu, Zn, Ga, Mo, Ru, Rh, Pd, Ag, In, Sn, Re, Ir and Pt.
Patent CA-2685026-A1 (CA)
Title: Cell search procedure for time division duplex communication systems using code division multiple access
Inventor: SEZGIN NADIR
IPC: H04B1/707
Filed: 2000-05-24
Abstract: A base station sends a synchronization signal in an assigned time slot to a user equipment in a time division duplex code division multiple access communication system. The base station has an assigned code group out of a predetermined number of code groups. The base station transmits selected secondary synchronization code signals out of a set of secondary synchronization code signals. The plurality of secondary synchronization code signals numbers less than half of the predetermined number of code groups. The user equipment identifies the transmitted selected secondary code signals. Based on in part the identified secondary synchronization code signals, the assigned code group is determined.
Patent CA-2685561-A1 (CA)
Title: Method and apparatus for connecting drilling riser strings and compositions thereof
Inventor: SAWTELL RALPH
IPC: F16L23/024
Filed: 2008-04-28
Abstract: In one embodiment, the present invention relates to a riser apparatus for use in offshore drilling for oil or other fossil fuels, the riser apparatus comprising: a plurality of riser sections coupled serially end-to-end, wherein each of the riser sections comprises: a tube having a first end and a second end; a first flanged that is mechanically joined to the first end of the tube; a second flanged that is mechanically joined to the second end of the tube; wherein the tube is constructed of an aluminum alloy; and wherein the flanges are constructed of the aluminum alloy; and wherein the riser apparatus has a length of approximately 1,500 meters or greater.
Patent CA-2685595-A1 (CA)
Title: Dechalcogenative methods for the preparation of allylic sulfides
Inventor: SUBRAMANIAN VENKATARAMAN
IPC: C07D319/14
Filed: 2008-04-29
Abstract: A dechalcogenative method for the preparation of an allylic sulfide comprises contacting an activated chalcogenide of Formula (I) with a thiol of Formula (II) for a period of time sufficient to form an intermediate of Formula (III), and supplying sufficient activation energy to the intermediate of Formula (III), in a suitable solvent, preferably in the absence of a phosphine or other thiophile, to induce a [2,3]-sigmatropic rearrangement therein to form an allylic sulfide of Formula (IV), with concomitant loss of chalcogen Z, as set forth in the following reaction scheme, wherein X is an activating group selected from the group consisting of CN, S-pyridyl, S-heteroaryl, SO2-aryl, and SO3Y; Y is an alkali metal ion; Z is Se or S; R1, R2, R3, R4, and R5 are each independently H or a hydrocarbon moiety; and R is an organic moiety.
Patent CA-2687663-A1 (CA)
Inventor: YOW D GREGORY
IPC: A61J1/14
Filed: 2008-05-16
Abstract: An attachment arrangement (10) has a housing (12) and a needle (34) located within the housing. The arrangement allows administration ports of different sizes to be inserted into and secured within the housing. In certain embodiments, compliant retainers (26) secure the administration port within the housing. In certain other embodiments, the administration port is secured within the housing when the housing is compressed against the administration port by a housing compression element (48). Once the administration port is secured within the housing, a fluid-tight seal is formed between the attachment device and the administration port.
Patent CA-2689274-A1 (CA)
Inventor: ANDRZEJ ROMAN BATT
IPC: C07D513/14
Filed: 2005-08-24
Abstract: The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V1a receptor antagonists.  Pharmaceutical compositions of the compounds are useful as treatment of primary dysmenorrhoea.     (see formula 1a)
Patent CA-2690151-A1 (CA)
Inventor: DAUGHERTY JOSEPH F
IPC: A61P25/16
Filed: 2008-06-04
Abstract: L'invention concerne une formulation de créatine par voie orale  qui comprend une créatine soluble et du polyéthylène glycol  et est enrobée au moyen d'un enrobage gastro-résistant. La  créatine soluble préférée est la créatine HCl.  Les polyéthylènes glycols préférés présentent  une masse moléculaire moyenne comprise entre 3150 et 3685, mais dans des  formulations particulières et pour des utilisations particulières,  les masses moléculaires moyennes des polyéthylènes glycols  peuvent être comprises entre 190 et 9000.
Patent CA-2691519-A1 (CA)
Inventor: KOKONASKI WILLIAM
IPC: G02C7/06
Filed: 2008-07-03
Abstract: A lens system is presented having a diffractive optical power region. The diffractive optical power region has a plurality of concentric surface relief diffractive structures. A greater portion of light incident on a diffractive structure near the center point contributes to the optical power than light incident on a diffractive structure peripherally spaced therefrom.
Patent CA-2692911-A1 (CA)
Inventor: PALLMANN HARTMUT
IPC: B02C18/16
Filed: 2010-02-10
Abstract: The invention relates to a device for comminuting scrappable feedstock by way of cutting or shear-cutting, comprising at least one rotor (14, 16) situated within a housing (2). The rotor (14, 16) has a plurality of rotary disks (19) which are situated at an axial distance from each other, forming spaces, and which are fitted on their circumferences with comminuting tools (21) which interact with additional comminuting tools (21; 38) to perform the comminution work. Stationary scraping elements (29) extend into the spaces in the radial direction. To achieve a largely unhindered flow of stock through the device, it is proposed according to the invention to situate the stationary scraping elements (29) in the dead zone of the at least one rotor (14, 16) with regard to the direction of stock flow (41, 42).
Patent CA-2693465-A1 (CA)
Inventor: GAIL ALFONS
IPC: B23Q11/08
Filed: 2008-07-02
Abstract: A sealing device for a coolant supply on a rotating spindle is characterized in that a first brush seal (4) and a second brush seal (5) are arranged one after another in series on the spindle (2) Hereby the technical problems of the prior art are avoided and an improved device is made available, which makes possible a reliable sealing of the supply of coolant to a quickly rotating tool spindle, which exhibits no sudden failure, and which nonetheless is cost-advantageous in production and installation.
Patent CA-2696436-A1 (CA)
Title: System and method for manufacturing an in-process part
Inventor: GRAHAM MICHAEL EVANS
IPC: G05B19/4097
Filed: 2010-03-11
Abstract: A method (40) and system (10) for manufacturing an in-process part (12) is provided.  The method (40) includes manufacturing (42) one or more primary features of the in-process part (12). The method also includes measuring (44) multiple locations and attributes of the manufactured in-process part including the primary features.  The method further includes designing (46) multiple optimal locations and attributes of multiple secondary features of the in-process part based on the measured locations and attributes of the manufactured in-process part and the primary features.  The method also includes manufacturing (48) one or more secondary features of the in-process part based on the optimal design locations and attributes of the secondary features.
Patent CA-2698585-A1 (CA)
Inventor: HEBRANK JOHN H
IPC: A01K43/00
Filed: 2008-09-22
Abstract: Methods and apparatus are provided that automatically determine whether or not eggs designated for removal from an egg carrier have been removed by an egg removal apparatus. Light is emitted along a path above and across an egg carrier as an egg picker moves to pick up an egg. The length of time that the light path is blocked when the egg picker is moved is measured and used to determine whether or not the egg has been removed from the carrier. Another apparatus and method is provided for detecting a malfunctioning egg picker. A detection device detects a number of eggs in the egg carrier. A control device monitors the egg picker and the detection device. The control device calculates the number of eggs in the egg carrier for determining when the number of eggs varies a predetermined amount from an egg count number for the egg carrier.
Patent CA-2699641-A1 (CA)
Inventor: STANESIC JOHN M
IPC: B60N3/04
Filed: 2009-08-06
Abstract: A vehicle floor tray has a base, upstanding side walls, a forward panel, and an aft wall that define a basin for confining liquid such as water, mud, and slush. An array of spaced apart chevron-shaped treads project upwardly from the base. The chevron-shaped treads are arranged in adjacent rows and the treads in each row are oriented in a direction opposite from the direction of orientation of the treads in adjacent rows. Further, each row of treads is shifted or staggered with respect to adjacent rows by a distance substantially equal to half the length of a tread plus half the distance between adjacent treads in a row. This configuration forms a convolutely shaped network contiguous channels within which liquid may collect and spread out. The shape of the channel network and the shapes and orientations of the chevron-shaped treads inhibits the mass flow of liquid to the front, back, or sides of the floor tray during acceleration, deceleration, and up or down hill traverses. This, in turn, inhibits puddeling of liquid during off-road operation of a vehicle and the problems attendant thereto.
Patent CA-2701519-A1 (CA)
Title: Piperidine and piperazine derivatives
Inventor: SCHIEMANN KAI
IPC: C07D277/68
Filed: 2008-09-19
Abstract: The invention relates to compounds of formula (I), in which R1, R2, R3, D, G, Q and W are defined as cited in claim (1). Said compounds can be used for treating tumours.
Patent CA-2702248-A1 (CA)
Inventor: KINCH MICHAEL
IPC: C07K16/00
Filed: 2008-10-23
Abstract: A method of inhibiting viral infection in a mammal in need of same, includes administering an effective amount of at least one of the compounds of FGI- 103 which are represented by 273, 365 and 510 either prophylactically to prevent viral infection, or therapeutically following viral infection. These compounds appear to selectively inhibit Caspase 8 as a method of preventing infective viral particle release. They can be administered IV, IP, orally or via other conventional administration routes.  The compounds are highly effective, requiring relatively low dosages on the order of 1 ng/kg - 200 mg/kg of body weight.
Patent CA-2704943-A1 (CA)
Inventor: HILL MALCOLM
IPC: A61K31/573
Filed: 2008-11-12
Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract for example those involving the esophagus Also provided herein
Patent CA-2705232-A1 (CA)
Inventor: BARNES JOHN ALAN
IPC: D01F6/60
Filed: 2008-10-29
Abstract: Multi-filament polyamide yarns characterized by high tenacity and low shrinkage are disclosed. Such yarns or fabrics made therefrom can be used in industrial applications in which such a combination of properties is desirable. Such yarns are particularly useful in the manufacture of automobile airbag fabrics. Also disclosed is a process for making such yarns.  The yarn manufacturing process involves spin-drawing molten nylon, relaxing and controlling the yarn tension, and then winding the yarn. Yarns made according to this process exhibit linear density in the range of 110 - 940 decitex, tenacity equal to or greater than 80 cN/tex, and shrinkage, measured at 177°C, of less than 5%.
Patent CA-2707620-A1 (CA)
Inventor: GEE JEFFERY C
IPC: C07C5/25
Filed: 2008-12-18
Abstract: The present disclosure describes methods for isomerizing olefins which produce isomerized products having low levels of skeletal isomerization. The methods use a combination of molecular sieve catalyst and isomerization reaction temperature, and weight hourly space velocity to achieve the low levels of skeletal isomerization.
Patent CA-2709915-A1 (CA)
Inventor: ABRAHMSEN LARS
IPC: A61K38/18
Filed: 2008-12-22
Abstract: HER2 binding polypeptides comprising the amino acid sequence EX, RNAYWEIA  LLPNLTNQQK RAFIRKLYDD  PSQSSELLX2E AKKLNDSQ wherein X1 in position 2 is M, I or L, and X2 in position 39 is S or C (SEQ ID NO:1 ) are disclosed. Moreover, such peptides comprising a chelating environment are disclosed. Also radiolabeled polypeptides formed by the peptides comprising a chelating environment and radionuclides are disclosed.  Furthermore, methods of in vivo imaging of the body of a mammalian subject having or suspected of having a cancer characterized by overexpression of HER2 comprising administration of such a radiolabeled polypeptide followed by obtainment of an image of the body using a medical imaging instrument and also methods of treating such cancer are disclosed. Furthermore, the use of such a radiolabeled polypeptide in diagnosis and treatment of cancer characterized by overexpression of HER2. Nucleic acids encoding the polypeptides, expression vectors comprising the nucleic acids and host cells comprising the expression vectors are also disclosed.
Patent CA-2710090-A1 (CA)
Inventor: CERVENKA JAN
IPC: C07C237/46
Filed: 2010-07-20
Abstract: This invention relates to an improved method for the synthesis of 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide ("Compound A"), an intermediate in the industrial preparation of non-ionic X-ray contrast agents. In particular, it relates to acetylation of 5-amino-N, N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide ("Compound B") using a reagent and solvent mixture containing between about 1.5 and about 3.0 liter of acetic anhydride and acetic acid per kilogram of Compound B. Preferably, following the acetylation reaction, the reagent and solvent mixture is distilled for re-use.
Patent CA-2710791-A1 (CA)
Title: Pyripyropene derivatives having an acat2-inhibiting activity
Inventor: TOMODA HIROSHI
IPC: A61P43/00
Filed: 2008-12-17
Abstract: The present invention is a compound having the general formula (I), (II), or (III) or a pharmacologically acceptable salt, solvate, or hydrate thereof, and a pharmaceutical composition containing such a compound, or its pharmacologically acceptable ester, or other pharmacologically acceptable derivative thereof as an active ingredient. The compound has an excellent ACAT 2-inihibiting activity by a mechanism different from that of a statin drug and is useful as a therapeutic or prophylactic agent for obesity, adiposis, hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, and arteriosclerosis, as well as obesity-derived hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, arteriosclerosis, and hypertension.
Patent CA-2711970-A1 (CA)
Inventor: FORBES OJO M
IPC: A47G19/18
Filed: 2010-08-10
Abstract: The invention provides mini condiment bottles with cap. The invention is produced for individual personal use. Main purpose is to be used to carry condiments to work or school. The bottle will be a 1 oz cylinder with twist cap closure that open and close by simply rotating the spout. when closed closure locks into place for spill proof storage.   Bottles will be specifically color dyed.
Patent CA-2717263-A1 (CA)
Inventor: TWIG NOAM
IPC: A45C5/00
Filed: 2010-10-06
Abstract: A container having a container portion with an interior space in which articles to be transported can be stored and a lid pivotably connected to the container portion.  The lid is moveable relative to the container portion between an opened and closed position. The container also includes a latch arrangement that is constructed to secure the lid in covering relation with respect to the container portion and a hinge structure that is constructed to enable the lid to pivot relative to the container portion. The container includes a support that engages a surface on which a bottom surface rests when the lid is in the opened position, so as to support the lid in the open position. The support is positioned proximate to the container portion when the lid is in the closed position and movable to an extended position when the lid is in the open position.
Patent CA-2717699-A1 (CA)
Title: Polyethylene glycolated lactoferrin complex and method of producing the same
Inventor: SATO ATSUSHI
IPC: A61K47/48
Filed: 2009-03-13
Abstract: There are provided a complex of lactoferrin with a hydrophilic, linear and non-peptide polymer which has a prolonged life in vivo and a high clinical usefulness due to its reduced antigenicity and imparted pepsin-resistance, and a method of producing the same. There are also provided a lactoferrin complex which sustains the biological activity of natural lactoferrin at a certain ratio, shows a significantly prolonged life in vivo and is superior in clinical usefulness to natural lactoferrin, a method of producing the same and the like.     One aspect of the invention relates to a method of producing a polyethylene glycolated lactoferrin complex wherein linear polyethylene glycol (PEG) or a modified product thereof is covalently bonded to lactoferrin via an amide bond, the method including causing a reaction in a reaction liquid, which contains lactoferrin and a linear PEG derivative having a para-nitrophenyl group, under conditions of allowing formation of an amide group between the para-nitrophenyl group and lactoferrin.
Patent CA-2719940-A1 (CA)
Title: Methods for treating acute myocardial infarction
Inventor: STEER RANDOLPH C
IPC: A61K38/48
Filed: 2009-03-26
Abstract: The present invention includes methods of treating acute myocardial infarction in a subject, comprising administer-ing to the subject a therapeutically effective amount of a non-proteolytically activated thrombin receptor agonist.
Patent CA-2721867-A1 (CA)
Inventor: DAVIS WILLIAM H
IPC: C10J3/46
Filed: 2008-04-18
Abstract: Two or more feed materials that possess differing syngas generation potentials are mixed in a mixer and fed as a composite feed stream into a gasifier to produce syngas. By controlling the feed rate of the mixture into the gasifier as well as the feed rates of one or more of the individual feed materials into the mixer, the syngas is produced at a target production rate, with target energy content (BTU). Potential feed materials include, but are not limited to, construction and demolition (C&D) debris, municipal solid waste (MSW), other sewage-related solids, waste tires, and other substances that contain varying levels of organic compounds capable of producing a syngas.
Patent CA-2722808-A1 (CA)
Inventor: WORTH JULIAN OTTO
IPC: G06Q20/00
Filed: 2009-05-05
Abstract: A system and method for managing the generation and the collection of financial contributions from holders of payment cards (50) and for distributing the collected contributions among a plurality of beneficiaries selected by the cardholders. The payment cards (50) have a unique identification (UID) that is associated with a contribution factor (CF) representing the cardholder's selected level of contribution to be made in proportion to the amount of transactions made with the card. A  selection of one or more beneficiaries such as charities, and where needed a distribution of these contributions among two or more beneficiaries is also associated with the card's unique identification. A payment card system (40,55) processes transactions in the normal way via a transaction network and provides data (43,45) that represent contributions proportional to the amount of transactions and that are paid using a merchant account held by a contributions processing entity (10,20). The latter provides data (80) representing a distribution of the collected contributions amongst the beneficiaries selected by the cardholders. The cardholder can select or modify the beneficiary data and optionally the contribution factor through the system's Internet site (30). Collection and distribution of the contributions is simple and flexible and the cardholder can alter the beneficiaries without this requiring any modification to the cards (50) or their coding.
Patent CA-2724877-A1 (CA)
Inventor: MUHAMMAD NAWEED
IPC: C07C229/00
Filed: 2009-05-20
Abstract: The present invention provides water-soluble acetaminophen prodrugs and formulations which may be suitable for parenteral administration. Methods of treating a disease or condition responsive to acetaminophen (such as fever and/or pain) using the acetaminophen prodrugs, as well as kits, unit dosages, and combinations with additional pharmaceutical agent(s) are also provided.